On Mar. 26, ND LEG enacted bill to study prescription drug pricing.
ND LEG enacted HB 1543, to provide for a legislative management study regarding prescription drug pricing and maximum fair price as determined by the government.
Document dated Mar. 26, 2025, was received on Apr. 24, 2025, due to a fixed feed.
Bill Provisions
The legislative management shall consider studying prescription drug pricing and the maximum fair price for a drug as published by the United States HHS secretary.
Must consider Federal inflation reduction act of (26 USC 55) drug price negotiations.
Study must overlap with current drugs paid for by the public employees retirement system to determine usage and potential cost-savings to the State and consumers.
Input is to be gathered from the public employees retirement system, the insurance commissioner, the state board of pharmacy, and other relevant stakeholders.
Legislative History
On Jan. 20, 2025, bill introduced in the House; on Feb. 10, 2025, bill passed House.
On Feb. 11, 2025, bill introduced into Senate; on Mar. 10, 2025, bill passed Senate.
On Mar. 24, 2025, delivered to governor; on Mar. 26, 2025, bill signed by the governor.
Effectiveness
Per ND Constitution, upon approval by governor, bill becomes effective Aug. 1, 2025.
Regulators
ND LEG
Entity Types
CNSM; Ins
Reference
Bill HB1543, 3/26/2025; Citation: 26 USC 55;
Functions
Claims/Accelerated Benefits; Compliance; Financial; Legal; Operations; Product Administration; Research
